Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
READ the full study in RAPM: #PhantomLimbPain #Cryoneurolysis #PainMedicine #RegionalAnesthesia #ClinicalResearch #Innovation To view or add a comment, sign in Ophthopedia Update:Mitomycin C in Non-Endoscopic Endonasal Dacryocystorhinostomy: A Randomized Clinical Trial involving 442 cases: Mitomycin C (MMC) is used as an adjuvant in endonasal endoscopic dacryocystorhinostomy (EN-DCR) despite the existing heterogeneity in the literature on the concentration, duration of application, indication and outcomes
Clinical trials show that patients lose 15% or more of their initial weight and experience improved cardiovascular health, better blood sugar control, and enhanced mobility
However, the risks for human patients developing thyroid C-cell tumors have not yet been determined
Any fuzzy growth, dark spots, or unusual formations mean immediate disposal
